OSL.XA - OncoSil Medical Limited

Cboe AU - Cboe AU Real-time price. Currency in AUD
Currency in AUD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.25
52-week change 3-75.47%
S&P500 52-week change 31.77%
52-week high 30.0650
52-week low 30.0090
50-day moving average 30.0145
200-day moving average 30.0404

Share statistics

Avg vol (3-month) 31.78M
Avg vol (10-day) 31.55M
Shares outstanding 5N/A
Implied shares outstanding 6N/A
Float 8832.52M
% held by insiders 111.57%
% held by institutions 12.44%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 June 2022
Most-recent quarter (mrq)31 Dec 2022

Profitability

Profit margin 0.00%
Operating margin (ttm)-842.60%

Management effectiveness

Return on assets (ttm)-85.40%
Return on equity (ttm)-177.27%

Income statement

Revenue (ttm)1.26M
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)32.90%
Gross profit (ttm)90.91k
EBITDA -10.63M
Net income avi to common (ttm)-10.68M
Diluted EPS (ttm)-0.0140
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)5.76M
Total cash per share (mrq)0.01
Total debt (mrq)222.76k
Total debt/equity (mrq)3.87
Current ratio (mrq)4.09
Book value per share (mrq)0.01

Cash flow statement

Operating cash flow (ttm)-10.02M
Levered free cash flow (ttm)-6.34M